A functional polymorphism in the matrix metalloproteinase-1 gene promoter is associated with susceptibility and aggressiveness of head and neck cancer
| Autor: | Pornchai O-charoenrat, Supatra Sangruchi, Piyavadee Leksrisakul |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Male
Cancer Research MMP1 Genotype Single-nucleotide polymorphism Biology Polymerase Chain Reaction Risk Factors Carcinoma medicine Odds Ratio Humans Genetic Predisposition to Disease Promoter Regions Genetic Genotyping Polymorphism Genetic Head and neck cancer Promoter Odds ratio Middle Aged medicine.disease Prognosis Molecular biology Oncology Head and Neck Neoplasms Carcinoma Squamous Cell Disease Progression Female Matrix Metalloproteinase 1 |
| Zdroj: | International journal of cancer. 118(10) |
| ISSN: | 0020-7136 |
| Popis: | Matrix metalloproteinases (MMPs) play an important role in several steps of cancer development. A single guanine insertion polymorphism (2G) in the MMP1 promoter sequence at -1,607 creates an Ets binding site and thus results in enhancing transcriptional activity. This study aimed to evaluate the contribution of this 2G polymorphism on susceptibility and aggressiveness of HNSCC. A panel of HNSCC cell lines and peritumoral fibroblasts were examined for the MMP1 genotypes and expression levels. Genomic DNA was extracted from peripheral blood of 300 patients with newly diagnosed HNSCC and from 300 age- and gender-matched cancer-free controls. Genotyping was carried out using a PCR-RFLP assay. The levels of MMP1 mRNA expression were evaluated by the quantitative RT-PCR and a correlation with different genotype was determined. Odds ratio (OR) for cancer risk were calculated using multivariate logistic regression. In addition, a correlation between the 2G/2G genotype and clinicopathological parameters was examined. Eleven out of 18 HNSCC cell lines showed the 2G/2G genotype (61%) and only 1 cell line had the 1G/1G genotype (5.6%). Cell lines with the 2G/2G genotype expressed significantly higher mean MMP1 mRNA level than those with other genotypes. In clinical model, subjects carrying the homozygous 2G/2G genotype had a higher risk of head and neck cancer compared with subjects with other genotypes (adjusted OR: 2.28; 95% CI: 1.58-3.27), controlling for major confounders. A correlation between promoter polymorphisms and the levels of MMP1 expression in cancer tissues was found, and this 2G/2G genotype was correlated with the adverse clinicopathological parameters. Finally, the highest level of MMP1 enhancement was demonstrated in the coculture of tumor cells and peritumoral fibroblasts of 2G homozygotes. These findings suggest that the presence of 2G polymorphism at the MMP1 promoter is associated with the development and progression of HNSCC. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text